Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation - Summary Of Performance Shares Activity (Details)

v3.20.2
Stock-Based Compensation - Summary Of Performance Shares Activity (Details) - Performance stock units
 9 Months Ended
Sep. 30, 2020
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]  
Outstanding at Beginning of Period (in shares) 522,621
Granted (in shares) 966,242
Target Shares Vested (in shares) (151,492)
Target Shares Forfeited (in shares) (295,780)
Outstanding at End of Period (in shares) 1,041,591
Weighted Average Grant Date Fair Value per Share (in dollars per share) | $ / shares $ 12.57
2017  
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]  
Outstanding at Beginning of Period (in shares) 151,492
Granted (in shares) 0
Target Shares Vested (in shares) (151,492)
Target Shares Forfeited (in shares) 0
Outstanding at End of Period (in shares) 0
Weighted Average Grant Date Fair Value per Share (in dollars per share) | $ / shares $ 10.73
2018  
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]  
Outstanding at Beginning of Period (in shares) 156,576
Granted (in shares) 0
Target Shares Vested (in shares) 0
Target Shares Forfeited (in shares) (72,254)
Outstanding at End of Period (in shares) 84,322
Weighted Average Grant Date Fair Value per Share (in dollars per share) | $ / shares $ 27.51
2019  
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]  
Outstanding at Beginning of Period (in shares) 214,553
Granted (in shares) 0
Target Shares Vested (in shares) 0
Target Shares Forfeited (in shares) (88,235)
Outstanding at End of Period (in shares) 126,318
Weighted Average Grant Date Fair Value per Share (in dollars per share) | $ / shares $ 27.49
2020  
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]  
Outstanding at Beginning of Period (in shares) 0
Granted (in shares) 966,242
Target Shares Vested (in shares) 0
Target Shares Forfeited (in shares) (135,291)
Outstanding at End of Period (in shares) 830,951
Weighted Average Grant Date Fair Value per Share (in dollars per share) | $ / shares $ 8.78